MAGAZINE: European investors experiment with life sciences
As life sciences companies race to expand across Europe’s top markets, the real estate industry prepares to experiment with a new alternative asset class.
This content is only available IPE Real Asset members
Already an IPE Real Assets Member? Sign in here
Unlock The PropertyEU Archive
PropertyEU has merged with IPE Real Assets
If you had a PropertyEU account, simply reset your password to get access to IPE Real Assets.
Otherwise, join IPE Real Assets for access to PropertyEU Archive.
What type of organisation do you work for?
IPE Real Assets Membership
IPE Real Assets has created a suite of products and services for Europe’s institutional real estate investment community.
Premium content
Pension fund interviews,
country analysis and data
country analysis and data
Opinion and analysis
Asset classes
and strategies in depth
and strategies in depth
IPE covers a good variety of very current and relevant topics. It is good to read the high-level, independent and objective perspectives from pension funds in other European countries; many of them are dealing with the same issues as we are, so it is interesting to learn from their experiences, especially when they are ahead of where we are on the curve.
Copyright © 1997–2025 IPE International Publishers Limited, Registered in England, Reg No. 3233596, VAT No. 685 1784 92. Registered Office: 1 Kentish Buildings, 125 Borough High Street, London SE1 1NP